Get 20% lifetime commission for referring investors to digrin.com
here.
DiaMedica Therapeutics Inc. (DMAC) Financials
DMAC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 45.0 million | 6.7 million |
| March 31, 2026 | 53.1 million | 5.8 million |
| Dec. 31, 2025 | 61.4 million | 5.3 million |
| Sept. 30, 2025 | 57.0 million | 5.4 million |
DMAC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -8.1 million | 1.1 million |
| March 31, 2026 | -9.1 million | 822000 |
| Dec. 31, 2025 | -7.8 million | 1.2 million |
| Sept. 30, 2025 | -6.6 million | 1.0 million |
DMAC Net Income
No data available :(
DMAC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 43.5 million | 69000 | - |
| March 31, 2026 | 51.3 million | 97000 | 115000 |
| Dec. 31, 2025 | 59.9 million | - | 240000 |
| Sept. 30, 2025 | 55.3 million | - | 157000 |
DMAC Shares Outstanding
DMAC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 3000 | 8.2 million | 2.3 million | - |
| March 31, 2026 | 8000 | 8.0 million | 2.5 million | - |
| Dec. 31, 2025 | 6000 | 6.7 million | 2.5 million | - |
| Sept. 30, 2025 | 16189 | 6.4 million | 2.6 million | - |
DMAC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 11000 |
| Dec. 31, 2025 | -27999 | 13999 |
| Sept. 30, 2025 | - | 18000 |
DMAC
Price: $6.62
52 week price:
Earnings Per Share: -0.71 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 67400
Market Capitalization: 357.0 million